EDV-GC

N/A

Report date: 2026/02/06 20:01:23

Base Information

Drug NameEDV-GC
Drug Alias NameEDV-GC
ClassificationCell and gene therapy > Cell therapy > Nano cell
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEngeneic Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEngeneic Pty Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A